Schmid College of Science and Technology, Food Science Program, Chapman University, Orange, CA, USA.
J Diet Suppl. 2021;18(1):44-56. doi: 10.1080/19390211.2019.1698687. Epub 2019 Dec 6.
The objective of this study was to analyze labeling practices and compliance with regulatory standards for shark cartilage supplements sold in the United States. The product labels of 29 commercial shark cartilage supplements were assessed for compliance with U.S. regulations. Claims, including nutrient content, prohibited disease, and nutritional support statements, were examined for compliance and substantiation. Overall, 48.3% of the samples had at least one instance of noncompliance with labeling regulations. The most common labeling violations observed were: missing a domestic address/phone number, non-compliant nutrient content claim, missing/incomplete disclaimer, missing statement of identity, prohibited disease claims, and incomplete "Supplement Facts" label. The use of prohibited disease claims and nutritional support statements without the required disclaimer is concerning from a public health standpoint because consumers may delay seeking professional treatment for a disease. The results of this study indicate a need for improved labeling compliance among shark cartilage supplements.
本研究旨在分析美国销售的鲨鱼软骨补充剂的标签实践和法规标准合规性。评估了 29 种商业鲨鱼软骨补充剂的产品标签,以确定其是否符合美国法规。检查了声称,包括营养成分、禁止疾病和营养支持声明,以确定其是否合规和有充分依据。总体而言,48.3%的样本至少有一次标签法规不合规的情况。观察到的最常见的标签违规行为包括:缺少国内地址/电话号码、不符合规定的营养成分声称、缺少/不完整的免责声明、缺少身份声明、禁止疾病声称和不完整的“补充事实”标签。从公共卫生的角度来看,使用未经要求的免责声明的禁止疾病声称和营养支持声明令人担忧,因为消费者可能会延迟寻求专业治疗疾病。本研究结果表明,鲨鱼软骨补充剂的标签合规性需要改进。